deltatrials
Completed PHASE4 INTERVENTIONAL NCT00195481

Study Evaluating Sirolimus in Kidney Transplant Recipients in India

A Post Marketing Surveillance Looking at Safety of Rapamune (Sirolimus) in Indian Population Undergoing de Novo Renal Transplantation.

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Conditions Graft vs Host Disease Kidney Failure
Interventions Rapamune
Updated 7 times since 2017 Last updated: Dec 21, 2007 Started: Apr 30, 2004 Primary completion: Dec 31, 2005 Completion: Dec 31, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Graft vs Host Disease and Kidney Failure, this trial is completed. The trial is conducted by Wyeth is now a wholly owned subsidiary of Pfizer and has accumulated 7 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Nov 2025 · 14 months · monthly snapshotCompleted~Nov 2025 – ~Feb 2026 · 3 months · monthly snapshotCompleted~Feb 2026 – present · 7 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed PHASE4

  2. Nov 2025 — Feb 2026 [monthly]

    Completed PHASE4

  3. Sep 2024 — Nov 2025 [monthly]

    Completed PHASE4

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  5. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Apr 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Wyeth is now a wholly owned subsidiary of Pfizer
Data source: Wyeth is now a wholly owned subsidiary of Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations